Skip to main content
. Author manuscript; available in PMC: 2010 Dec 1.
Published in final edited form as: Ophthalmology. 2009 Oct 7;116(12):2286–2293. doi: 10.1016/j.ophtha.2009.05.026

Table 5. Multivariate Analysis for Factors Associated with Change of Adherence Rate between 3 and 6 Months for Randomized Intervention and Control Groups (N=62*).

Factors N Adherence rate change from 3 months Adjusted Mean (SE) P-value§
Treatment Group 0.0001
 Control 28 -0.002 (0.04)
 Intervention 34 0.21 (0.05)
Adherence rate at Month 3 0.003
 <=0.50 26 0.18 (0.04)
 0.501-0.75 36 0.03 (0.05)
Race 0.02
 Black 37 0.04 (0.04)
 White 25 0.17 (0.05)
Education 0.051
 < High School 8 0.09 (0.07)
 High School 16 0.18 (0.05)
 College 24 0.01 (0.05)
 Graduate School 14 0.14 (0.06)
I have used travoprost without using the device during the study 0.12
 Never 43 0.14 (0.04)
 Ever 19 0.06 (0.05)
Use of medicine 0.16
 Unilateral 17 0.04 (0.05)
 Bilateral 45 0.16 (0.03)
Age (yrs) 0.65
 <50 7 0.11 (0.08)
 50 -59 11 0.07 (0.06)
 60-69 21 0.16 (0.05)
 70-79 16 0.13 (0.05)
 >=80 7 0.05 (0.07)
Length of time on glaucoma medication 0.67
 <= 1 year 9 0.09 (0.07)
 > 1 year 53 0.12 (0.03)
*

3 patients were excluded from the multivariate analysis due to missing value in education status (n=2) and use of travoprost without using the device during the study (n=1), Asian was also excluded due to small number (n=1).

SE = standard error; yrs = years

§

From one-way analysis of variance

Note: All the independent variables included in the multivariate model are listed above.